Bar Harbor Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $365K | Buy |
2,888
+100
| +4% | +$13.2K | 0.02% | 209 |
|
|
2026
Q1 | $389K | Sell |
2,788
-7
| -0.3% | -$980 | 0.02% | 201 |
|
|
2025
Q4 | $343K | Sell |
2,795
-124
| -4% | -$15.1K | 0.02% | 213 |
|
|
2025
Q3 | $324K | Hold |
2,919
| – | – | 0.02% | 213 |
|
|
2025
Q2 | $324K | Sell |
2,919
-50
| -2% | -$5.32K | 0.02% | 209 |
|
|
2025
Q1 | $333K | Sell |
2,969
-10
| -0.3% | -$1.03K | 0.02% | 203 |
|
|
2024
Q4 | $275K | Sell |
2,979
-270
| -8% | -$24.3K | 0.02% | 219 |
|
|
2024
Q3 | $272K | Hold |
3,249
| – | – | 0.02% | 236 |
|
|
2024
Q2 | $223K | Sell |
3,249
-519
| -14% | -$34.6K | 0.01% | 243 |
|
|
2024
Q1 | $276K | Sell |
3,768
-250
| -6% | -$19.2K | 0.02% | 221 |
|
|
2023
Q4 | $325K | Sell |
4,018
-200
| -5% | -$15.6K | 0.02% | 209 |
|
|
2023
Q3 | $316K | Sell |
4,218
-55
| -1% | -$4.23K | 0.03% | 206 |
|
|
2023
Q2 | $329K | Hold |
4,273
| – | – | 0.03% | 209 |
|
|
2023
Q1 | $355K | Hold |
4,273
| – | – | 0.03% | 204 |
|
|
2022
Q4 | $367K | Sell |
4,273
-550
| -11% | -$43.6K | 0.03% | 207 |
|
|
2022
Q3 | $298K | Sell |
4,823
-2
| -0% | -$126 | 0.03% | 218 |
|
|
2022
Q2 | $298K | Buy |
+4,825
| New | +$299K | 0.02% | 224 |
|
|
2020
Q1 | – | Sell |
-4,079
| Closed | -$265K | – | 250 |
|
|
2019
Q4 | $265K | Sell |
4,079
-6,048
| -60% | -$394K | 0.03% | 258 |
|
|
2019
Q3 | $642K | Buy |
10,127
+95
| +0.9% | +$6.21K | 0.07% | 184 |
|
|
2019
Q2 | $678K | Sell |
10,032
-879
| -8% | -$57.8K | 0.08% | 177 |
|
|
2019
Q1 | $709K | Sell |
10,911
-384
| -3% | -$25.5K | 0.09% | 167 |
|
|
2018
Q4 | $707K | Sell |
11,295
-3,033
| -21% | -$212K | 0.09% | 155 |
|
|
2018
Q3 | $1.11M | Buy |
14,328
+93
| +0.7% | +$7.02K | 0.13% | 133 |
|
|
2018
Q2 | $1.01M | Sell |
14,235
-1,779
| -11% | -$126K | 0.12% | 135 |
|
|
2018
Q1 | $1.21M | Buy |
16,014
+1,207
| +8% | +$95.9K | 0.15% | 122 |
|
|
2017
Q4 | $1.06M | Buy |
14,807
+4,433
| +43% | +$337K | 0.12% | 135 |
|
|
2017
Q3 | $840K | Sell |
10,374
-1,695
| -14% | -$130K | 0.1% | 147 |
|
|
2017
Q2 | $854K | Sell |
12,069
-1,249
| -9% | -$83.1K | 0.1% | 151 |
|
|
2017
Q1 | $905K | Sell |
13,318
-5,408
| -29% | -$380K | 0.11% | 146 |
|
|
2016
Q4 | $1.34M | Sell |
18,726
-515
| -3% | -$38.3K | 0.15% | 118 |
|
|
2016
Q3 | $1.52M | Buy |
19,241
+5,958
| +45% | +$484K | 0.17% | 105 |
|
|
2016
Q2 | $1.11M | Buy |
13,283
+543
| +4% | +$48.2K | 0.13% | 126 |
|
|
2016
Q1 | $1.17M | Buy |
12,740
+289
| +2% | +$26.1K | 0.14% | 119 |
|
|
2015
Q4 | $1.26M | Buy |
12,451
+159
| +1% | +$16.5K | 0.16% | 112 |
|
|
2015
Q3 | $1.21M | Sell |
12,292
-159
| -1% | -$17.7K | 0.16% | 110 |
|
|
2015
Q2 | $1.46M | Buy |
12,451
+570
| +5% | +$62.3K | 0.18% | 105 |
|
|
2015
Q1 | $1.17M | Buy |
11,881
+1,649
| +16% | +$167K | 0.14% | 114 |
|
|
2014
Q4 | $964K | Buy |
10,232
+2,848
| +39% | +$295K | 0.12% | 129 |
|
|
2014
Q3 | $786K | Sell |
7,384
-71
| -1% | -$6.95K | 0.1% | 142 |
|
|
2014
Q2 | $618K | Buy |
7,455
+495
| +7% | +$38.5K | 0.08% | 165 |
|
|
2014
Q1 | $493K | Sell |
6,960
-140
| -2% | -$11K | 0.06% | 183 |
|
|
2013
Q4 | $533K | Hold |
7,100
| – | – | 0.07% | 177 |
|
|
2013
Q3 | $446K | Buy |
7,100
+530
| +8% | +$31.7K | 0.06% | 182 |
|
|
2013
Q2 | $337K | Buy |
+6,570
| New | +$342K | 0.05% | 199 |
|
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Bar Harbor Wealth Management's GILD Position: Q2 2026 in Review
Bar Harbor Wealth Management increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $13.2K and bringing the position to 2,888 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #209.
Bar Harbor Wealth Management first reported a position in GILD in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.52M in Q3 2016. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Bar Harbor Wealth Management held 2,888 shares of Gilead Sciences worth $365K as of Q2 2026.
- Bar Harbor Wealth Management bought 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
- Gilead Sciences made up 0.02% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #209 holding.
- Bar Harbor Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 44 quarters since.
- Bar Harbor Wealth Management's Gilead Sciences position peaked at $1.52M in Q3 2016.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.